V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270018901 | 270019885 | null | 79.7 | Palliative (P) | 2015-08-13 | 2016-01-27 | CETUXIMAB | N | N | 270012832 | CETUXIMAB |
| 270018902 | 270008482 | null | 84.5 | Curative (C) | 2017-05-24 | 2017-05-28 | Escalated BEACOPP | N | N | 270012897 | BEACOPP |
| 270018903 | 270008484 | 0 | null | Curative (C) | 2017-12-02 | 2017-12-04 | COPP + Dacarbazine | N | null | 270012904 | COPP + DACARBAZINE |
| 270018904 | 270008487 | 1.8 | null | Curative (C) | 2017-11-19 | 2018-07-03 | CETUXIMAB | 2 | Y | 270012909 | CETUXIMAB |
| 270018905 | 270008495 | 1.66 | 73.8 | Curative (C) | 2016-12-17 | 2016-12-25 | Cetuximab 14 day | N | N | 270012948 | CETUXIMAB |
| 270018906 | 270008497 | 1.76 | 56.4 | Curative (C) | 2015-04-23 | 2015-07-04 | Trial Unspecified | 02 | null | 270012949 | TRIAL |
| 270018907 | 270016682 | 0 | 55.2 | Curative (C) | 2018-01-22 | 2018-02-20 | COPP + Dacarbazine | N | N | 270012966 | COPP + DACARBAZINE |
| 270018908 | 270008503 | 1.5 | null | Curative (C) | 2014-05-24 | 2015-01-31 | Cetuximab 7 day (Cycle 1) | N | null | 270012975 | CETUXIMAB |
| 270018909 | 270008512 | 0 | 100 | null | null | 2015-09-08 | BEACOPP | N | N | 270013020 | BEACOPP |
| 270018910 | 270008518 | 1.73 | 85 | null | 2018-02-09 | 2018-04-19 | BEACOPP-14 | N | N | 270013029 | BEACOPP |
| 270018911 | 270014037 | 1.74 | 61.8 | Curative (C) | 2014-01-30 | 2014-02-06 | CETUXIMAB | 02 | N | 270013128 | CETUXIMAB |
| 270018912 | 270008536 | 1.7 | 89 | null | 2013-09-29 | 2014-01-19 | COPP + Dacarbazine | null | Y | 270013143 | COPP + DACARBAZINE |
| 270018913 | 270008542 | 1.75 | null | Curative (C) | 2016-05-21 | 2016-05-21 | BEACOPP-14 | N | N | 270013162 | BEACOPP |
| 270018914 | 270008549 | 0 | 81 | Adjuvant (A) | 2017-01-31 | 2017-01-31 | COPP + Dacarbazine | N | N | 270013196 | COPP + DACARBAZINE |
| 270018915 | 270008554 | 1.66 | 54.3 | Palliative (P) | 2015-10-14 | 2015-10-14 | Trial Unspecified | N | N | 270013221 | TRIAL |
| 270018916 | 270016695 | 1.69 | 33.3 | Disease modification (D) | 2016-09-17 | 2017-01-28 | BEACOPP-14 | 2 | N | 270013228 | BEACOPP |
| 270018917 | 270014050 | 0 | 35.1 | null | 2017-09-21 | 2017-09-25 | COPP + Dacarbazine | N | N | 270013279 | COPP + DACARBAZINE |
| 270018918 | 270008585 | 1.67 | 59.2 | Curative (C) | 2015-01-04 | 2015-01-25 | HD EuroNet-PHL-C1 COPDAC | 01 | N | 270013366 | TRIAL |
| 270018919 | 270008587 | 0 | null | Curative (C) | 2017-10-14 | 2017-10-31 | COPP + Dacarbazine | null | N | 270013367 | COPP + DACARBAZINE |
| 270018920 | 270014063 | 0 | 80.1 | Adjuvant (A) | 2016-10-10 | 2016-12-13 | COPP + Dacarbazine | N | null | 270013410 | COPP + DACARBAZINE |
| 270018921 | 270008607 | 0 | 56 | Curative (C) | null | 2017-12-04 | COPP + Dacarbazine | N | null | 270013475 | COPP + DACARBAZINE |
| 270018922 | 270018230 | 1.83 | null | Curative (C) | 2015-09-06 | 2016-10-15 | Cetuximab 14 day | N | N | 270013483 | CETUXIMAB |
| 270018923 | 270008613 | 2 | 69.1 | Curative (C) | 2014-07-10 | 2014-07-10 | Escalated BEACOPP | 2 | N | 270013488 | BEACOPP |
| 270018924 | 270008620 | 1.78 | 96.1 | Palliative (P) | 2014-06-12 | 2014-06-17 | CETUXIMAB | N | N | 270013509 | CETUXIMAB |
| 270018925 | 270014072 | 0 | 78.1 | Palliative (P) | 2016-09-07 | 2016-10-08 | HD EuroNet-PHL-C1 COPDAC | N | N | 270013529 | TRIAL |
| 270018926 | 270008626 | 1.5 | 88 | Neo-adjuvant (N) | 2015-05-02 | 2015-05-03 | CETUXIMAB | 2 | N | 270013544 | CETUXIMAB |
| 270018927 | 270008633 | 1.8 | 60.7 | Disease modification (D) | 2015-10-19 | 2016-01-13 | Trial Unspecified | N | null | 270013582 | TRIAL |
| 270018928 | 270016711 | 1.6 | 72.3 | Curative (C) | 2013-06-16 | 2013-08-28 | Escalated BEACOPP | N | null | 270013582 | BEACOPP |
| 270018929 | 270008635 | 1.5 | 118.4 | Curative (C) | 2017-09-30 | 2017-09-30 | COPP + Dacarbazine | 02 | N | 270013590 | COPP + DACARBAZINE |
| 270018930 | 270020052 | 1.69 | 91 | Palliative (P) | 2017-06-08 | 2017-06-22 | Rituximab | N | null | 270013711 | RITUXIMAB |
| 270018931 | 270008651 | 1.96 | 85 | Curative (C) | 2015-09-15 | 2015-10-12 | OEPA | N | null | 270013762 | OEPA |
| 270018932 | 270008654 | 1.55 | 84 | null | 2016-08-08 | 2016-11-02 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270013773 | CISPLATIN + RT |
| 270018933 | 270008678 | null | 77.55 | Curative (C) | 2017-12-31 | 2017-12-31 | BMT BEAM | N | N | 270013969 | BEAM |
| 270018934 | 270018245 | 1.75 | 61 | Curative (C) | 2017-02-24 | 2017-10-29 | ESHAP | 02 | N | 270013992 | ESHAP |
| 270018935 | 270008706 | 1.58 | 53.9 | Curative (C) | 2014-11-22 | 2015-02-02 | Cisplatin + Radiotherapy | N | N | 270014097 | CISPLATIN + RT |
| 270018936 | 270008713 | 1.78 | 91.8 | Curative (C) | 2013-08-22 | 2014-06-24 | Mini BEAM | N | N | 270014163 | BEAM |
| 270018937 | 270014119 | 0.98 | 81 | Curative (C) | 2016-07-14 | 2016-07-16 | ESHAP | N | N | 270014196 | ESHAP |
| 270018938 | 270008728 | 1.83 | null | Curative (C) | null | 2015-04-21 | BEAM | N | N | 270014220 | BEAM |
| 270018939 | 270008735 | 1.61 | 79.2 | Curative (C) | 2016-07-24 | 2017-03-17 | BEAM | 2 | N | 270014243 | BEAM |
| 270018940 | 270008739 | 1.77 | null | Disease modification (D) | 2017-03-24 | 2018-01-09 | Rituximab | N | Y | 270014256 | RITUXIMAB |
| 270018941 | 270008744 | 1.71 | 84.4 | Curative (C) | 2018-12-08 | 2019-03-11 | LEAM | N | N | 270014274 | LEAM |
| 270018942 | 270016743 | 1.6 | 100 | Curative (C) | 2014-09-09 | 2014-09-13 | BEAM | N | N | 270014291 | BEAM |
| 270018943 | 270008748 | 0 | 81.4 | Palliative (P) | 2018-03-11 | 2018-05-07 | Cetuximab + FOLFIRI cycle1 | 2 | N | 270014308 | CETUXIMAB + IRINOTECAN + MDG |
| 270018944 | 270008756 | 1.78 | 84.4 | Curative (C) | 2014-10-26 | 2014-10-28 | OEPA | 02 | Y | 270014363 | OEPA |
| 270018945 | 270014142 | 1.7 | null | Curative (C) | 2018-04-08 | 2018-04-15 | BEAM | N | N | 270014409 | BEAM |
| 270018946 | 270008780 | null | null | Disease modification (D) | null | 2016-05-08 | Rituximab | 02 | N | 270014418 | RITUXIMAB |
| 270018947 | 270008783 | 1.51 | 65 | Curative (C) | 2018-03-31 | 2018-04-02 | OEPA | 2 | N | 270014427 | OEPA |
| 270018948 | 270014147 | 1.72 | 87.9 | Curative (C) | 2017-01-11 | 2017-01-11 | OEPA | N | N | 270014444 | OEPA |
| 270018949 | 270019623 | 1.71 | 63 | Curative (C) | null | 2018-09-29 | ESHAP | N | N | 270014445 | ESHAP |
| 270018950 | 270008802 | 1.88 | 118 | Not known (9) | 2017-06-19 | 2017-08-30 | Rituximab | N | Y | 270014452 | RITUXIMAB |